"For Everyone" Is Code for "For No One." Pick Your Segment.

01 /The Concept

Calibre is an app for understanding your current health status – and more importantly, for figuring out how to improve it.

Subscribers effectively get a dedicated health team: diagnostic testing, medical experts, and an AI that monitors their health daily, gives recommendations, and is available to answer questions at any time.

Calibre claims the equivalent breadth and quality of service would typically cost around £5,000 (roughly $6,800) through traditional medicine. On the platform, it costs £69/month (roughly $94) when billed annually, or £79/month on a quarterly plan – there's no month-to-month option.

The diagnostic testing protocol is personalized based on age, health history, existing conditions, and other individual factors.

Test results are combined with personal medical history, family health history, lifestyle information, and data automatically pulled from fitness trackers and other wearables.

All of this aggregated data produces a comprehensive picture of the subscriber's current health status and the risks associated with their genetics, history, and lifestyle.

From that picture, the user sets current strategic health goals – say, reducing cardiovascular risk and/or building lean muscle mass. Calibre's AI then builds a comprehensive plan to achieve those goals.

The key insight: subscribers don't need to memorize their plan. The app simply tells them each day what to do and what to avoid – covering daily habits like training, walks, nutrition, and sleep, as well as recurring check-ins: periodic calls with Calibre's medical experts and regular diagnostic retests.

Those periodic consultations assess and interpret current health metrics, which may trigger strategic adjustments. Once a new strategy is set, the AI resumes managing the daily tactics within that framework.

Calibre is a British startup. It launched its app last year and has now closed its first funding round: £2.5M (roughly $3.4M), which the company characterizes as pre-seed given how much runway remains in the product roadmap.

02 /Why It Matters

One notable aspect of Calibre's positioning: its target audience isn't sick people – it's healthy ones. Though as doctors say, there are no truly healthy people, only underdiagnosed ones.

As Calibre describes the shift: until a few years ago, most people defined "health" as "absence of illness." You assumed things were fine until they weren't. When symptoms appeared, you saw a doctor to address them – then went back to not thinking about your health.

Today, Calibre argues, people want more than that: sufficient physical and mental reserves to actually live fully.

The problem is that health-conscious people today often find themselves paralyzed. Too much data, too many contradictory interpretations online, no clear path from information to action.

The result: you either make uninformed guesses on your own, or you try to do everything at once – which can produce negligible results or even backfire.

Wealthy individuals and elite athletes have always solved this by assembling personal health teams that make decisions and design reliable strategies for them. Everyone else has operated in DIY mode – guesswork, influence from health influencers, self-directed decisions.

Yes, you can now ask AI assistants your health questions. In fact, a major AI provider launched a dedicated health product earlier this year that already has 230 million users.

But general-purpose AI still can't substitute for individualized medical care – which requires comprehensive personal data, diagnostic tests, and human experts capable of interpreting everything in the context of one specific person.

Calibre targets the "sophisticated" segment that understands this distinction and is willing to pay meaningfully for the difference.

That audience will always be a minority. Calibre's stated goal is 100 million users – which sounds ambitious in isolation, but if a mass-market health AI product already has 230 million users, the total addressable population might reasonably be estimated at around one billion. One hundred million is roughly 10% of that – which is about the standard ratio between early adopters and the general market in any category.

Calibre has wisely picked a large enough market that even its 10% slice represents enormous potential: 100 million users at ~$100/month.

03 /Opportunities

Two broadly applicable lessons emerge from this review.

Any market has two distinct segments – sophisticated users and mainstream users – and you need to pick one. If you're targeting sophisticated users, don't chase mass-market scale and don't compromise the product to appeal to a lower-consideration buyer. Don't be afraid to sell a service that not everyone can appreciate, or to charge accordingly – competing on price within the premium segment, not against mass-market alternatives. Calibre benchmarks its pricing against the £5,000 that wealthy individuals and elite athletes currently pay for comparable care. The real constraint is whether 10% of your total addressable market is big enough to satisfy your ambitions.

Worth layering on top: for AI platforms targeting sophisticated segments, it's almost always worth separating the strategy layer from the tactics layer.

Strategy – the big directional decisions – should be set and validated by humans, even if AI assists. Humans verify, adapt to context, and take accountability.

Tactics – the daily execution of that strategy – is exactly the kind of repetitive, precise, always-on work that AI handles best, running 24/7 without fatigue.

As a cross-industry example: Fifr ([covered here](/review/ty-doverish-ii-upravljat-svoimi-dengami)) raised $1.5M for a personal investing service where a human expert selects the right investment strategy for each user, and the platform's AI executes it. Fifr's subscription also runs at roughly $100/month.

So: is there a market where you'd want to build a service for sophisticated users? What advanced capabilities would that service need to offer? Are people already paying substantial sums for comparable services today? What would you charge – and is the addressable pool of qualified payers large enough to support your ambitions?

A recent illustration from a very different category: Atlas ([covered here](/review/nastojashhaja-cel-jeto-pribyl)) raised $40M for a premium payment card with $1,000/year in annual fees, offering exclusive access to reservations at otherwise-inaccessible restaurants, luxury hotel bookings, and premium event tickets. Its target is people spending $500K+ per year on their current premium cards. If the cardholder base grows from 2,000 to 10,000, Atlas earns $100M per year in interchange alone.

So – what's your "not for everyone" angle, and which category would you want to take it into?